• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DAB2IP 通过抑制 PI3K/AKT 信号通路稳定 clear cell renal cell carcinoma 中的 p27。

DAB2IP stabilizes p27 via suppressing PI3K/AKT signaling in clear cell renal cell carcinoma.

机构信息

Department of Urology, Shaanxi Provincial People's Hospital, Xi'an, 710068, Shaanxi, China.

Department of Gynecology, Shaanxi Provincial People's Hospital, Xi'an, 710068, Shaanxi, China.

出版信息

Funct Integr Genomics. 2023 Oct 25;23(4):326. doi: 10.1007/s10142-023-01255-1.

DOI:10.1007/s10142-023-01255-1
PMID:37880458
Abstract

Renal cell carcinoma (RCC) is the most lethal of the urologic malignancies. We previously discovered that DAB2IP, a novel Ras GTPase-activating protein, was frequently epigenetically silenced in RCC, and DAB2IP loss was correlated with the overall survival of RCC patients. In this study, we determined the biological functions of DAB2IP in clear cell RCC (ccRCC) and its potential mechanisms of action. Correlations between DAB2IP expression level and ccRCC tumor size and patient survival were analyzed, and the results showed that ccRCC patients with high DAB2IP mRNA level exhibited smaller tumor size and better survival than the patients with low DAB2IP. Compared to control, DAB2IP knockdown significantly increased cell proliferation, promoted cell cycle progression in G1/S phase, and decreased p27 expression. Mechanism studies demonstrated that loss of DAB2IP promoted p27 protein phosphorylation, cytosolic sequestration, and subsequently ubiquitination-mediated degradation in ccRCC cells. Further studies confirmed that the proline-rich domain in C terminal (CPR) of DAB2IP suppressed AKT phosphorylation and p27 phosphorylation on S10. Hence, DAB2IP is essential for p27 protein stabilization in ccRCC, which is at less partly mediated by PI3K/AKT signaling pathway.

摘要

肾细胞癌(RCC)是最致命的泌尿系统恶性肿瘤之一。我们之前发现,DAB2IP,一种新型的 Ras GTPase 激活蛋白,在 RCC 中经常被表观遗传沉默,DAB2IP 的缺失与 RCC 患者的总生存相关。在这项研究中,我们确定了 DAB2IP 在透明细胞肾细胞癌(ccRCC)中的生物学功能及其潜在的作用机制。分析了 DAB2IP 表达水平与 ccRCC 肿瘤大小和患者生存的相关性,结果表明,DAB2IP mRNA 水平高的 ccRCC 患者肿瘤体积较小,生存状况较好。与对照相比,DAB2IP 敲低显著增加了细胞增殖,促进了 G1/S 期细胞周期进程,并降低了 p27 的表达。机制研究表明,DAB2IP 的缺失促进了 ccRCC 细胞中 p27 蛋白的磷酸化、细胞质隔离,随后被泛素化介导降解。进一步的研究证实,DAB2IP 的 C 端富含脯氨酸结构域(CPR)抑制了 AKT 磷酸化和 p27 在 S10 上的磷酸化。因此,DAB2IP 对 ccRCC 中 p27 蛋白的稳定是必不可少的,这部分是由 PI3K/AKT 信号通路介导的。

相似文献

1
DAB2IP stabilizes p27 via suppressing PI3K/AKT signaling in clear cell renal cell carcinoma.DAB2IP 通过抑制 PI3K/AKT 信号通路稳定 clear cell renal cell carcinoma 中的 p27。
Funct Integr Genomics. 2023 Oct 25;23(4):326. doi: 10.1007/s10142-023-01255-1.
2
DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.DOC-2/DAB2 互作蛋白通过靶向 PI3K/Akt 通路调节鼻咽癌细胞的增殖和迁移。
Oncol Rep. 2017 Jul;38(1):317-324. doi: 10.3892/or.2017.5704. Epub 2017 Jun 6.
3
PLAUR facilitates the progression of clear cell renal cell carcinoma by activating the PI3K/AKT/mTOR signaling pathway.PLAUR 通过激活 PI3K/AKT/mTOR 信号通路促进肾透明细胞癌的进展。
PeerJ. 2024 Jun 27;12:e17555. doi: 10.7717/peerj.17555. eCollection 2024.
4
Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis.ACHN 细胞来源的外泌体 microRNA-15a 通过 BTG2/PI3K/AKT 轴加重肾透明细胞癌。
Kaohsiung J Med Sci. 2021 Nov;37(11):973-982. doi: 10.1002/kjm2.12428. Epub 2021 Aug 1.
5
miR-92b promotes gastric cancer growth by activating the DAB2IP-mediated PI3K/AKT signalling pathway.miR-92b 通过激活 DAB2IP 介导的 PI3K/AKT 信号通路促进胃癌生长。
Cell Prolif. 2020 Jan;53(1):e12630. doi: 10.1111/cpr.12630. Epub 2019 Nov 12.
6
Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma PI3K/AKT Signaling Pathway.微绒毛蛋白 1(TUFT1)促进肾细胞癌 PI3K/AKT 信号通路的增殖和迁移。
Pathol Oncol Res. 2021 Apr 19;27:640936. doi: 10.3389/pore.2021.640936. eCollection 2021.
7
Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.浸润性T细胞通过改变雌激素受体β-DAB2IP信号促进肾细胞癌(RCC)进展。
Oncotarget. 2015 Dec 29;6(42):44346-59. doi: 10.18632/oncotarget.5884.
8
LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.长链非编码RNA TP73-AS1通过抑制KISS1表达及PI3K/Akt/mTOR信号通路失活促进透明细胞肾细胞癌的细胞增殖并抑制细胞凋亡。
Cell Physiol Biochem. 2018;48(1):371-384. doi: 10.1159/000491767. Epub 2018 Jul 17.
9
DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis.DAB2IP 协调 PI3K-Akt 和 ASK1 通路以促进细胞存活和凋亡。
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):19878-83. doi: 10.1073/pnas.0908458106. Epub 2009 Nov 10.
10
HOXA6 inhibits cell proliferation and induces apoptosis by suppressing the PI3K/Akt signaling pathway in clear cell renal cell carcinoma.HOXA6 通过抑制 PI3K/Akt 信号通路抑制肾透明细胞癌细胞增殖并诱导细胞凋亡。
Int J Oncol. 2019 Jun;54(6):2095-2105. doi: 10.3892/ijo.2019.4789. Epub 2019 Apr 16.

引用本文的文献

1
A Systematic Analysis of Expression and Function of RAS GTPase-Activating Proteins (RASGAPs) in Urological Cancers: A Mini-Review.泌尿系统癌症中RAS鸟苷三磷酸酶激活蛋白(RASGAPs)表达与功能的系统分析:一篇综述短文
Cancers (Basel). 2025 Apr 28;17(9):1485. doi: 10.3390/cancers17091485.
2
An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications. RasGAP 蛋白 DAB2IP 的抑瘤功能最新研究进展及其治疗意义
Cell Death Differ. 2024 Jul;31(7):844-854. doi: 10.1038/s41418-024-01332-3. Epub 2024 Jun 20.
3
DAB2IP inhibits glucose uptake by modulating HIF-1α ubiquitination under hypoxia in breast cancer.
DAB2IP在乳腺癌缺氧条件下通过调节HIF-1α泛素化抑制葡萄糖摄取。
Oncogenesis. 2024 Jun 11;13(1):20. doi: 10.1038/s41389-024-00523-4.
4
Analyzing the Antihyperglycemic Effect of Cissus quadrangularis and Bacopa monnieri on 3T3-L1 Cell Lines.分析四角金虎尾和假马齿苋对3T3-L1细胞系的降血糖作用。
Cureus. 2024 Jan 21;16(1):e52661. doi: 10.7759/cureus.52661. eCollection 2024 Jan.